Translate Bio, A Sanofi Company

Biotechnology ResearchMassachusetts, United States51-200 Employees

Translate Bio, A Sanofi Company, is a mid-sized biotechnology firm focused on clinical-stage messenger RNA therapeutics. It is based in Lexington, Massachusetts, and operates within the biotechnology research industry as part of Sanofi's expanded mRNA capabilities after a September 2021 acquisition. The acquisition added a pillar to Sanofi's mRNA Center of Excellence, enabling work in next-generation mRNA vaccines and applications across immunology, oncology, and rare diseases. 

The unit contributes to Sanofi's global health initiatives by pursuing RNA-based vaccine and therapeutic approaches. Its target markets include healthcare providers and patients around the world, with emphasis on addressing needs in vaccines and in rare and chronic diseases. Sanofi has engaged in initiatives such as partnerships to advance clinical-trial methods, including digital control groups for virtual trials, illustrating the broader program Translate Bio participates in within the Sanofi ecosystem.

Sign up for free to view info

Email Format Employee directory